Ireland - English - HPRA (Health Products Regulatory Authority)

generics (uk) limited - fusidic acid, betamethasone valerate - cream - 20 + 1 mg/g - corticosteroids, potent, combinations with antibiotics - corticosteroids, potent, combination with antibiotic - it is indicated for the treatment of eczematous dermatoses including atopic eczema, infantile eczema (children of 1 year and over), discoid eczema, stasis eczema, contact eczema and seborrhoeic eczemawhen secondary bacterial infection is confirmed or suspected

Ireland - English - HPRA (Health Products Regulatory Authority)

meda health sales ireland limited - azelastine hydrochloride; fluticasone propionate - nasal spray, suspension - 137/50 microgram(s) - corticosteroids; fluticasone, combinations

Ireland - English - HPRA (Health Products Regulatory Authority)

meda health sales ireland limited - azelastine hydrochloride; fluticasone propionate - nasal spray, suspension - 137/50 microgram(s) - corticosteroids; fluticasone, combinations

Ireland - English - HPRA (Health Products Regulatory Authority)

mylan ire healthcare limited - azelastine hydrochloride; fluticasone propionate - nasal spray, suspension - 137 µg/50 microgram(s) - corticosteroids; fluticasone, combinations

Ireland - English - HPRA (Health Products Regulatory Authority)

mylan ire healthcare limited - azelastine hydrochloride; fluticasone propionate - nasal spray, suspension - 137mcg/50 microgram(s) - corticosteroids; fluticasone, combinations

Ireland - English - HPRA (Health Products Regulatory Authority)

viatris healthcare limited - azelastine hydrochloride; fluticasone propionate - nasal spray, suspension - corticosteroids; fluticasone, combinations

Israel - English - Ministry of Health

organon pharma israel ltd., israel - betamethasone as dipropionate; gentamicin (as sulfate) - cream - gentamicin (as sulfate) 1 mg/g; betamethasone as dipropionate 0.5 mg/g - corticosteroids, potent, combinations with antibiotics - for the relief of the inflammatory manifestations of corticosteroid-responsive dermatoses when complicated by secondary infections caused by organisms susceptible to gentamycin.

Israel - English - Ministry of Health

padagis israel pharmaceuticals ltd, israel - clotrimazole; dexamethasone acetate; neomycin sulfate - cream - clotrimazole 1 %; neomycin sulfate 0.645 %; dexamethasone acetate 0.044 % - combinations - combinations - treatment of dermatitis involving also a bacterial and/or fungal infection.

Israel - English - Ministry of Health

organon pharma israel ltd., israel - betamethasone acetate; betamethasone sodium phosphate - suspension for injection - betamethasone acetate 3 mg/ml; betamethasone sodium phosphate 3.945 mg/ml - betamethasone - betamethasone - indicated in the management of conditions known to be responsive to corticosteroid therapy.

Israel - English - Ministry of Health

kamada ltd, israel - beclometasone dipropionate anhydrous; formoterol fumarate dihydrate - pressurised solution - formoterol fumarate dihydrate 6 mcg/dose; beclometasone dipropionate anhydrous 100 mcg/dose - formoterol and beclometasone - beclometasone - foster is indicated in the regular treatment of asthma where use of a combination product (inhaled corticosteroid and long-acting beta2-agonist) is appropriate:- patients not adequately controlled with inhaled corticosteroids and 'as needed' inhaled rapid-acting beta2-agonist or- patients already adequately controlled on both inhaled corticosteroids and long-acting beta2-agonists.copd :symptomatic treatment of patients with severe copd (fev1 < 50% predicted normal) and a history of repeated exacerbations, who have significant symptoms despite regular therapy with long-acting bronchodilators.